Literature DB >> 25193354

Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.

Pengpeng Xu1, Dong Yu, Li Wang, Yang Shen, Zhixiang Shen, Weili Zhao.   

Abstract

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous subtype of non-Hodgkin's lymphoma. This study aims to better define the prognostic factors and compare the predictive value of the prognostic scores in Chinese patients with PTCL-NOS. One hundred and five patients diagnosed as PTCL-NOS from our institution were retrospectively studied and grouped according to four previously described prognostic scores [International Prognostic Index (IPI), Prognostic Index for PTCL-NOS (PIT), modified PIT (m-PIT), and International PTCL Project (IPTCLP)]. In addition to clinical parameters, peripheral lymphopenia and thrombocytopenia, serum Epstein-Barr virus positivity, and tumor Ki-67 were significantly associated with poor disease outcome. Multivariate analysis revealed that age >60 years, poor performance status, elevated lactic dehydrogenase, and bone marrow involvement were independent adverse variables for survival. All prognostic scores were successful for survival estimation. Risk subgroups in IPI and PIT could be further discriminated by platelet count (IPTCLP factor) and Ki-67 (m-PIT factor), respectively. Together, patient- and tumor-specific characteristics may be incorporated in risk stratification of PTCL-NOS patients. The prognostic scores could be mutually active to improve their predictive value of disease outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25193354     DOI: 10.1007/s00277-014-2188-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Utility of bone marrow aspirate and biopsy in staging of patients with T-cell lymphoma in the PET-Era - tissue remains the issue.

Authors:  Suchitra Sundaram; Mazen Jizzini; Dominick Lamonica; Kristopher Attwood; Matthew Gravina; Francisco Hernandez-Ilizaliturri; Pallawi Torka
Journal:  Leuk Lymphoma       Date:  2020-08-04

2.  Pegylated liposomal-encapsulated doxorubicin in cutaneous composite lymphoma: A case report.

Authors:  Uwe Wollina; Dana Langner; Gesina Hansel; Gunter Haroske
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER.

Authors:  Yajun Li; Kailin Chen; Chaohui Zuo; Ruolan Zeng; Yizi He; Xiaoyan Chen; Ling Xiao; Hui Zhou
Journal:  Int J Gen Med       Date:  2021-11-17

4.  Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma.

Authors:  Yu Ri Kim; Soo-Jeong Kim; June-Won Cheong; Haerim Chung; Ji Eun Jang; Yundeok Kim; Woo-Ick Yang; Yoo Hong Min; Jin Seok Kim
Journal:  Oncotarget       Date:  2017-09-23

5.  Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.

Authors:  Qing Shi; Rong Shen; Chao-Fu Wang; Xing Fan; Ying Qian; Bin-Shen Ou-Yang; Yan Zhao; Christophe Leboeuf; Anne Janin; Shu Cheng; Li Wang; Wei-Li Zhao
Journal:  Mediators Inflamm       Date:  2017-09-17       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.